Recursion Pharmaceuticals continues to have a pipeline of drugs that might provide further validation for the company's platform. See why I rate RXRX a Sell.

Recursion Pharmaceuticals (RXRX) stock gains as the company plans a 20% workforce reduction to streamline operations and extend cash runway to Q4 2027. Read more here.

But Recursion says it is getting better results since replacing that earlier version with Boltz-2, not just for virtual screening and hit identification but also for lead optimization.

A familiar face in a new position appeared with Falling in Reverse during their Rock Am Ring and Rock Im Park appearances this past weekend.

The Supreme Court on Thursday sided with a straight woman in Ohio who filed a “reverse discrimination” lawsuit against her employer when her gay boss declined to promote her. The ruling will ...

The Supreme Court on Thursday revived a lawsuit from an Ohio woman who claimed she was the victim of reverse discrimination.

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning ...

Automotive presenter and farmer Jeremy Clarkson uploaded a promotional tweet after Oscar Piastri reversed his way out of the grass in Australia.

Contribute to rchen00/Algorithms-in-Python development by creating an account on GitHub.